insulin lispro-aabc 100 UNT/ML Injectable Solution
Managing this medication for someone you care for? Eleplan keeps diagnoses, medications and appointments in one plan.
Start free with EleplanClinical drug
insulin lispro-aabc 100 UNT/ML Injectable Solution
100 UNT/ML · Injectable Solution · injection
A form of insulin lispro-aabc →
insulin lispro-aabc 100 UNT/ML Injectable Solution — Insulins and analogues for injection, fast-acting. Strength, form, class, interactions & more.
Active ingredient
Classification
Insulins and analogues for injection, fast-actingInsulin Analog
Drug interactions
LYUMJEV has several clinically significant drug interactions that may affect blood glucose levels.
- majorantidiabetic agents — may increase the risk of hypoglycemia
- majorACE inhibitors — may increase the risk of hypoglycemia
- majorangiotensin II receptor blocking agents — may increase the risk of hypoglycemia
- majordisopyramide — may increase the risk of hypoglycemia
- majorfibrates — may increase the risk of hypoglycemia
- majorfluoxetine — may increase the risk of hypoglycemia
- majormonoamine oxidase inhibitors — may increase the risk of hypoglycemia
- majorpentoxifylline — may increase the risk of hypoglycemia
- majorpramlintide — may increase the risk of hypoglycemia
- majorsalicylates — may increase the risk of hypoglycemia
- majorsomatostatin analogs (e.g., octreotide) — may increase the risk of hypoglycemia
- majorsulfonamide antibiotics — may increase the risk of hypoglycemia
- majoratypical antipsychotics (e.g., olanzapine and clozapine) — may decrease the blood glucose lowering effect of LYUMJEV
- majorcorticosteroids — may decrease the blood glucose lowering effect of LYUMJEV
- majordanazol — may decrease the blood glucose lowering effect of LYUMJEV
- majordiuretics — may decrease the blood glucose lowering effect of LYUMJEV
- majorestrogens — may decrease the blood glucose lowering effect of LYUMJEV
- majorglucagon — may decrease the blood glucose lowering effect of LYUMJEV
- majorisoniazid — may decrease the blood glucose lowering effect of LYUMJEV
- majorniacin — may decrease the blood glucose lowering effect of LYUMJEV
- majororal contraceptives — may decrease the blood glucose lowering effect of LYUMJEV
- majorphenothiazines — may decrease the blood glucose lowering effect of LYUMJEV
- majorprogestogens (e.g., in oral contraceptives) — may decrease the blood glucose lowering effect of LYUMJEV
- majorprotease inhibitors — may decrease the blood glucose lowering effect of LYUMJEV
- majorsomatropin — may decrease the blood glucose lowering effect of LYUMJEV
- majorsympathomimetic agents (e.g., albuterol, epinephrine, terbutaline) — may decrease the blood glucose lowering effect of LYUMJEV
- majorthyroid hormones — may decrease the blood glucose lowering effect of LYUMJEV
- majoralcohol — may increase or decrease the blood glucose lowering effect of LYUMJEV
- majorbeta-blockers — may blunt signs and symptoms of hypoglycemia
- majorclonidine — may blunt signs and symptoms of hypoglycemia
- majorguanethidine — may blunt signs and symptoms of hypoglycemia
- majorreserpine — may blunt signs and symptoms of hypoglycemia
- majorpentamidine — may cause hypoglycemia, which may sometimes be followed by hyperglycemia
Real-world adverse events (FAERS)
Blood Glucose Increased543Infusion Site Pain263Injection Site Pain214Drug Ineffective207Wrong Technique in Product Usage Process153Incorrect Dose Administered138Blood Glucose Decreased101Product Dose Omission Issue69
Source: RxNorm + openFDA + RxClass + FAERS · 2026
Look up another medication